[
  {
    "ts": "2026-02-13T00:22:55+00:00",
    "headline": "West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook",
    "summary": "In the past week, West Pharmaceutical Services reported its 2025 results, with full-year sales rising to US$3.07 billion and net income edging up to US$493.7 million, while also issuing 2026 guidance that calls for first-quarter net sales of US$770 million to US$790 million and full-year net sales of US$3.22 billion to US$3.28 billion, including a foreign-exchange benefit. An important detail in that outlook is that organic net sales growth is expected to outpace reported growth,...",
    "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-5-002255335.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "55246e5f-e7bb-3c35-b982-e71b3a41a1fd",
      "content": {
        "id": "55246e5f-e7bb-3c35-b982-e71b3a41a1fd",
        "contentType": "STORY",
        "title": "West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook",
        "description": "",
        "summary": "In the past week, West Pharmaceutical Services reported its 2025 results, with full-year sales rising to US$3.07 billion and net income edging up to US$493.7 million, while also issuing 2026 guidance that calls for first-quarter net sales of US$770 million to US$790 million and full-year net sales of US$3.22 billion to US$3.28 billion, including a foreign-exchange benefit. An important detail in that outlook is that organic net sales growth is expected to outpace reported growth,...",
        "pubDate": "2026-02-13T00:22:55Z",
        "displayTime": "2026-02-13T00:22:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-5-002255335.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-5-002255335.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-13T12:13:16+00:00",
    "headline": "West Pharmaceutical Services Q4 Earnings Call Highlights",
    "summary": "West Pharmaceutical Services (NYSE:WST) said it ended 2025 with fourth-quarter results above its own expectations, citing strong demand for high-value product (HVP) components, continued progress on Annex 1-driven upgrades, and ongoing growth tied to GLP-1 therapies. Management also introduced initi",
    "url": "https://www.marketbeat.com/instant-alerts/west-pharmaceutical-services-q4-earnings-call-highlights-2026-02-13/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "8b2dd325-b1c0-370e-b1e6-76a8fcb9dcce",
      "content": {
        "id": "8b2dd325-b1c0-370e-b1e6-76a8fcb9dcce",
        "contentType": "STORY",
        "title": "West Pharmaceutical Services Q4 Earnings Call Highlights",
        "description": "",
        "summary": "West Pharmaceutical Services (NYSE:WST) said it ended 2025 with fourth-quarter results above its own expectations, citing strong demand for high-value product (HVP) components, continued progress on Annex 1-driven upgrades, and ongoing growth tied to GLP-1 therapies. Management also introduced initi",
        "pubDate": "2026-02-13T12:13:16Z",
        "displayTime": "2026-02-13T12:13:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/76abae430f89162370876f7e880ed071",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "West Pharmaceutical Services logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HlfmF1HTuvKMNHK4DWupMw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/76abae430f89162370876f7e880ed071.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BDWUHhRWNb.nRBDutLDCvQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/76abae430f89162370876f7e880ed071.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/west-pharmaceutical-services-q4-earnings-call-highlights-2026-02-13/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-q4-earnings-121316607.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-13T16:40:02+00:00",
    "headline": "COO vs. WST: Which Stock Is the Better Value Option?",
    "summary": "COO vs. WST: Which Stock Is the Better Value Option?",
    "url": "https://finance.yahoo.com/news/coo-vs-wst-stock-better-164002961.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3497e018-a3ff-379e-b12a-976c5255710d",
      "content": {
        "id": "3497e018-a3ff-379e-b12a-976c5255710d",
        "contentType": "STORY",
        "title": "COO vs. WST: Which Stock Is the Better Value Option?",
        "description": "",
        "summary": "COO vs. WST: Which Stock Is the Better Value Option?",
        "pubDate": "2026-02-13T16:40:02Z",
        "displayTime": "2026-02-13T16:40:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2",
          "originalWidth": 900,
          "originalHeight": 625,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3cJ1IMl6d4bpPpYAD.IsQw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2.cf.webp",
              "width": 900,
              "height": 625,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PlkanZFCHurVHg.4Kx4ifw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/coo-vs-wst-stock-better-164002961.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/coo-vs-wst-stock-better-164002961.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]